Global Companion Animal Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Companion Animal Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
In this report, we study the Veterinary Products for Companion Animals mainly medicines, vaccines and others.
Some of the most popular companion animals are likely dogs and cats; other animals commonly kept may include pigs, red foxes, ferrets, and rabbits; rodents such as gerbils, hamsters, chinchillas, fancy rats, and guinea pigs; avian pets, such as canaries, parrots, and fowl; reptile pets, such as turtles, lizards and snakes; aquatic pets, such as fish, freshwater and saltwater aquatic snails, frogs; arthropod pets, such as tarantulas and hermit crabs, and many other species.
Companion animals (dogs, cats, and horses) have come to play an important part in the lives of many people. They provide companionship and a sense of responsibility, demand care and attention, and respond with affection.
Companion Animal Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Companion Animal Vaccines market is projected to reach US$ 23080 million in 2034, increasing from US$ 15530 million in 2022, with the CAGR of 5.7% during the period of 2024 to 2034. Demand from Canine and Avian are the major drivers for the industry.
Market competition is intense. Boehringer Ingelheim, Zoetis, Elanco Animal Health, Bayer Animal Health, Merck Animal Health and Virbac etc. are the leaders of the industry, and they hold key technologies and patents. Market share of Top 6 player is about 66%. America is the largest consumption place, with a revenue market share nearly 43%. Following America, Europe is the second largest consumption place with the revenue market share of 19%. China is the region with high growth potential.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Companion Animal Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer
Vetoquinol
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck
Merial
Segment by Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Canine
Avian
Feline
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Companion Animal Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Companion Animal Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Companion Animal Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Companion Animal Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Companion Animal Vaccines introduction, etc. Companion Animal Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Companion Animal Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Some of the most popular companion animals are likely dogs and cats; other animals commonly kept may include pigs, red foxes, ferrets, and rabbits; rodents such as gerbils, hamsters, chinchillas, fancy rats, and guinea pigs; avian pets, such as canaries, parrots, and fowl; reptile pets, such as turtles, lizards and snakes; aquatic pets, such as fish, freshwater and saltwater aquatic snails, frogs; arthropod pets, such as tarantulas and hermit crabs, and many other species.
Companion animals (dogs, cats, and horses) have come to play an important part in the lives of many people. They provide companionship and a sense of responsibility, demand care and attention, and respond with affection.
Companion Animal Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Companion Animal Vaccines market is projected to reach US$ 23080 million in 2034, increasing from US$ 15530 million in 2022, with the CAGR of 5.7% during the period of 2024 to 2034. Demand from Canine and Avian are the major drivers for the industry.
Market competition is intense. Boehringer Ingelheim, Zoetis, Elanco Animal Health, Bayer Animal Health, Merck Animal Health and Virbac etc. are the leaders of the industry, and they hold key technologies and patents. Market share of Top 6 player is about 66%. America is the largest consumption place, with a revenue market share nearly 43%. Following America, Europe is the second largest consumption place with the revenue market share of 19%. China is the region with high growth potential.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Companion Animal Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer
Vetoquinol
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck
Merial
Segment by Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Segment by Application
Canine
Avian
Feline
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Companion Animal Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Companion Animal Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Companion Animal Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Companion Animal Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Companion Animal Vaccines introduction, etc. Companion Animal Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Companion Animal Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices